查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
光免疫疗法的全球市场，各治疗领域、各终端用户、各地区:竞争、预测、机会 (2027年)
市场调查报告书
商品编码
1131715

光免疫疗法的全球市场，各治疗领域、各终端用户、各地区:竞争、预测、机会 (2027年)

Global Photoimmunotherapy Market By Therapeutic Area, By End User, and By Region, Competition Forecast and Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球光免疫疗法市场，在预测期间内 (2023年～2027年) 预计目击强劲的年复合成长率。

全球癌症罹患率增加，医疗费增加，为发现新癌症治疗方法的研究开发 (R&D) 活动的进展等要素，牵引市场需求。还有医疗基础设施整备和僱用熟练的医护人员的主要机关的投资增加，政府的有利偿付政策，成为能加速今后5年光免疫疗法全球市场成长的其他显着的要素。

本报告提供全球光免疫疗法的市场相关分析，整体市场规模趋势预测和市场占有率结构 (各治疗领域、各终端用户)，各地区、主要国家详细趋势，主要的推动及阻碍市场要素，企业间的市场竞争结构，主要企业的简介，今后的市场成长的方向性等调查。

目录

第1章 产品概要

第2章 分析方法

第3章 摘要整理

第4章 COVID-19对全球光免疫疗法市场的影响

第5章 客户方面的见解

  • 治疗的意识
  • 癌症的盛行率:男女
  • 癌症的盛行率:各年龄层
  • 癌症的盛行率:各地区

第6章 临床实验分析

第7章 专利分析

第8章 全球光免疫疗法市场:未来展望

  • 市场规模与其预测
    • 以金额为准
  • 市场占有率与其预测
    • 各治疗领域 (头颈椎癌症，转移性黑色素瘤，其他)
    • 各终端用户 (医院、诊疗所，门诊病人治疗中心，生物科技、製药公司，其他)
    • 各企业 (2021年)
    • 各地区
  • 产品市场地图

第9章 北美的光免疫疗法市场预测

  • 市场规模与其预测
  • 市场占有率与预测
    • 各治疗领域
    • 各终端用户
    • 各国
  • 北美:各国分析
    • 美国的光免疫疗法市场预测
    • 墨西哥的光免疫疗法市场预测
    • 加拿大的光免疫疗法市场预测

第10章 欧洲的光免疫疗法市场预测

  • 市场规模与其预测
  • 市场占有率与预测
  • 欧洲:各国分析
    • 法国的光免疫疗法市场预测
    • 德国的光免疫疗法市场预测
    • 英国的光免疫疗法市场预测
    • 义大利的光免疫疗法市场预测
    • 西班牙的光免疫疗法市场预测

第11章 亚太地区的光免疫疗法市场预测

  • 市场规模与其预测
  • 市场占有率与预测
  • 亚太地区:各国分析
    • 中国的光免疫疗法市场预测
    • 印度的光免疫疗法市场预测
    • 韩国的光免疫疗法市场预测
    • 日本的光免疫疗法市场预测
    • 澳洲的光免疫疗法市场预测

第12章 南美的光免疫疗法市场预测

  • 市场规模与其预测
  • 市场占有率与预测
  • 南美:各国分析
    • 巴西的光免疫疗法市场预测
    • 阿根廷的光免疫疗法市场预测
    • 哥伦比亚的光免疫疗法市场预测

第13章 中东、非洲的光免疫疗法市场预测

  • 市场规模与其预测
  • 市场占有率与预测
  • 中东、非洲:各国分析
    • 南非的光免疫疗法市场预测
    • 沙乌地阿拉伯的光免疫疗法市场预测
    • 阿拉伯联合大公国的光免疫疗法市场预测

第14章 市场动态

  • 促进因素
  • 课题

第15章 市场趋势和动静

第16章 竞争情形

  • Rakuten Medical, Inc.
  • Shimadzu Corporation
  • Modulight Corporation
  • Steba Biotech Ltd.
  • Luzitin SA

第17章 策略性建议

简介目录
Product Code: 12819

The global photoimmunotherapy market is anticipated to witness robust CAGR in the forecast period, 2023-2027. Factors such as the increasing prevalence of cancer worldwide, growing healthcare expenditure, and ongoing research and development activities to find novel cancer treatment therapies primarily drive the demand for the global photoimmunotherapy market. The rise in the investments by the leading authorities to develop the healthcare infrastructure and hire skilled healthcare professionals and favorable government reimbursement policies are the other prominent factors that can accelerate the global photoimmunotherapy market growth over the next five years.

Increased Cancer Prevalence Worldwide Drives the Market Growth

Cancer is a major health concern and is a leading cause of death across the globe. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020. During cancer, there is the rapid creation of abnormal cells that grow beyond their usual boundaries and can invade the adjoining parts of the body and spread to other organs, and the process is called metastasis. Some of the most common kinds of cancer are breast, lung, colon, rectum, and prostate cancers. In 2020, due to lung cancer, around 1.0 million deaths were observed. Similarly, for colon and rectum and liver cancer, the number of deaths in 2020 was 916000 and 830000. Adoption of an unhealthy and sedentary lifestyle, high body mass index, high alcohol, and tobacco consumption, and low fruit and vegetable intake are the main cancer-causing factors. Approximately 400 000 children develop cancer every year, and cervical cancer is the most common cancer in 23 countries. Cancer can be reduced through early detection and the right treatment and care of the patients. The majority of cancers can be cured if detected and treated early. Photoimmunotherapy is the recently developed hybrid cancer therapy that directly kills cancer cells as well as produces a therapeutic host immune response. Conventional immunotherapies such as checkpoint inhibition, engineered T cells and suppressor cell depletion, and immune-activating cytokine therapy do not directly destroy the cancer cells and rely on activating the immune system. Photoimmunotherapy selectively destroys the cancer cells, which releases cancer antigens from dying cancer cells. Therefore, the increased cancer incidence worldwide and the high mortality rate due to cancer are expected to bolster the global photoimmunotherapy market growth over the forecast period.

Favorable Government Policies Supports the Market Growth

The government of various countries are concerned with the growing number of cancer cases and are taking steps to lower the patient mortality rate due to cancer. They are providing financial support, reimbursing the cost incurred during the cancer treatment procedures, and funding cancer treatment research and development activities, among others. For instance, in India, some of the steps taken by the government that can fund cancer treatment are Health Minister's Cancer Patient Fund, The Health Minister's Discretionary Grants, The Central Government Health Scheme (CGHS), National Health Protection Scheme and The Prime Minister's National Relief Fund. Leading authorities of various countries are also promoting the adoption of novel technologies to treat cancer effectively. Massive support from the governments is making the market players invest and find new solutions for cancer treatment. Therefore, supportive government policies and the entry of new market players are expected to play a major role in boosting the global photoimmunotherapy market growth over the next five years.

Market Segmentation

The global photoimmunotherapy market is segmented into therapeutic area, end user, regional distribution, and competitive landscape. Based on therapeutic area, the market is divided into head & neck cancer, metastatic melanoma, and others. Based on end user, the market is divided into hospitals & clinics, ambulatory care centers, biotechnology & pharmaceutical companies, and others. The market analysis also studies the regional segmentation, which is divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to hold a significant market share due to the early adoption of advanced technologies by the healthcare sector and the presence of major market players in the country.

Market Players

Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., Luzitin SA are the major market players operating in the global photoimmunotherapy market.

Report Scope:

In this report, global photoimmunotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Photoimmunotherapy Market, By Therapeutic Area:

  • Head & Neck Cancer
  • Metastatic Melanoma
  • Others

Photoimmunotherapy Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Biotechnology & Pharmaceutical Companies
  • Others

Photoimmunotherapy Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global photoimmunotherapy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Photoimmunotherapy Market

5. Voice of Customer

  • 5.1. Therapy Awareness
  • 5.2. Cancer Prevalence, By Gender
  • 5.3. Cancer Prevalence, By Age Group
  • 5.4. Cancer Prevalence, By Region

6. Clinical Trial Analysis

7. Patent Analysis

8. Global Photoimmunotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others)
    • 8.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others)
    • 8.2.3. By Company (2021)
    • 8.2.4. By Region
  • 8.3. Product Market Map

9. North America Photoimmunotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutic Area
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Photoimmunotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutic Area
        • 9.3.1.2.2. By End User
    • 9.3.2. Mexico Photoimmunotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutic Area
        • 9.3.2.2.2. By End User
    • 9.3.3. Canada Photoimmunotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutic Area
        • 9.3.3.2.2. By End User

10. Europe Photoimmunotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutic Area
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. Europe: Country Analysis
    • 10.3.1. France Photoimmunotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutic Area
        • 10.3.1.2.2. By End User
    • 10.3.2. Germany Photoimmunotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutic Area
        • 10.3.2.2.2. By End User
    • 10.3.3. United Kingdom Photoimmunotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutic Area
        • 10.3.3.2.2. By End User
    • 10.3.4. Italy Photoimmunotherapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Therapeutic Area
        • 10.3.4.2.2. By End User
    • 10.3.5. Spain Photoimmunotherapy Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Therapeutic Area
        • 10.3.5.2.2. By End User

11. Asia-Pacific Photoimmunotherapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutic Area
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. Asia-Pacific: Country Analysis
    • 11.3.1. China Photoimmunotherapy Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutic Area
        • 11.3.1.2.2. By End User
    • 11.3.2. India Photoimmunotherapy Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutic Area
        • 11.3.2.2.2. By End User
    • 11.3.3. South Korea Photoimmunotherapy Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutic Area
        • 11.3.3.2.2. By End User
    • 11.3.4. Japan Photoimmunotherapy Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Therapeutic Area
        • 11.3.4.2.2. By End User
    • 11.3.5. Australia Photoimmunotherapy Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Therapeutic Area
        • 11.3.5.2.2. By End User

12. South America Photoimmunotherapy Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Therapeutic Area
    • 12.2.2. By End User
    • 12.2.3. By Country
  • 12.3. South America: Country Analysis
    • 12.3.1. Brazil Photoimmunotherapy Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Therapeutic Area
        • 12.3.1.2.2. By End User
    • 12.3.2. Argentina Photoimmunotherapy Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Therapeutic Area
        • 12.3.2.2.2. By End User
    • 12.3.3. Colombia Photoimmunotherapy Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Therapeutic Area
        • 12.3.3.2.2. By End User

13. Middle East and Africa Photoimmunotherapy Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Therapeutic Area
    • 13.2.2. By End User
    • 13.2.3. By Country
  • 13.3. MEA: Country Analysis
    • 13.3.1. South Africa Photoimmunotherapy Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Therapeutic Area
        • 13.3.1.2.2. By End User
    • 13.3.2. Saudi Arabia Photoimmunotherapy Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Therapeutic Area
        • 13.3.2.2.2. By End User
    • 13.3.3. UAE Photoimmunotherapy Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Therapeutic Area
        • 13.3.3.2.2. By End User

14. Market Dynamics

  • 14.1. Drivers
  • 14.2. Challenges

15. Market Trends & Developments

16. Competitive Landscape

  • 16.1. Rakuten Medical, Inc.
  • 16.2. Shimadzu Corporation
  • 16.3. Modulight Corporation
  • 16.4. Steba Biotech Ltd.
  • 16.5. Luzitin SA

17. Strategic Recommendations